Children and adults with rheumatic heart disease in low- and middle-income countries face high mortality and morbidity, highlighting the critical need for early detection and treatment programs.
High mortality persists in young RHD patients in LMICs; leaves open whether enhanced screening improves outcomes in prospective studies.
Patients with clinical rheumatic heart disease have high mortality and morbidity despite being young; those from low- and lower-middle-income countries had a poorer prognosis associated with advanced disease and low education. Programs focused on early detection and the treatment of clinical rheumatic heart disease are required to improve outcomes.
No takes yet. Share an insight, caveat, or question.
Zühlke et al. (2016) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: